AstraZeneca (AZN) Appoints Michel Demare as Incoming Board Chair
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Tech stocks pull Wall Street lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
AstraZeneca (AZN) Tops Q2 EPS by 93c, Beats on Revenue
July 29, 2022 5:58 AM EDTAstraZeneca (NASDAQ: AZN) reported Q2 EPS of $1.72, $0.93 better than the analyst estimate of $0.79. Revenue for the quarter came in at $10.77 billion versus the consensus estimate of $10.51 billion.
For earnings history and earnings-related data on AstraZeneca (AZN) click here.
... More